Reaktives Testergebnis

Screening tests are built to miss as little as possible, so they also react to samples that turn out negative on a second, more specific test. That is why the result is called reactive and not positive. The word is chosen on purpose, and using it correctly is the difference between a calm conversation and a frightened customer.

Three things follow for a pharmacy team.

First, a reactive result is never communicated as a finding. Reading a value out loud, calling it good or bad, or naming a condition crosses from advice into diagnosis, which is not a pharmacy's role. The Aufklärung und Einwilligung the customer signed before the draw sets out what happens with the sample, and interpreting it is not on that list.

Second, the timing of the sample matters. A reactive result can be a real early signal, or it can be the diagnostische Lücke working against you, where the sample was taken too soon after exposure for the answer to be reliable. Either way the answer is the confirmatory test, and the akkreditiertes Labor that produced the result names which one.

Third, the handover has to be written down before it is needed. This written route is the Eskalationspfad, the escalation path, and one line in the Standardarbeitsanweisung, agreed with the cooperating physician, is enough. It should say who is informed, in what order, how quickly, and what exactly the customer hears, so nobody has to improvise in front of a queue.

It helps to know how the wording reaches the counter in the first place. A laboratory report marks a value that falls outside the Referenzbereich and, for a screening assay, labels the finding reactive rather than positive. The pharmacy passes that document on unchanged and names the doctor who arranges the next step.

What the customer hears can be short, and shorter is better. The test has reacted, that is not yet a result, a second test is needed before anything can be said, and here is who arranges it. Nothing beyond those four points needs to be said at the counter.